Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Clinical Genetics|April 1, 1978
Genetic control of human plasma creatine phosphokinase activityH Y Meltzer, E Dorus, L Grunhaus, et al.Psychiatry Research|October 1, 1988
Plasma postdexamethasone cortisol levels in schizoaffective disorderJ H Meador-Woodruff, J F Greden, L Grunhaus, et al.International Journal of Psychiatry in Clinical Practice|June 14, 2014
Transcranial magnetic stimulation is effective in the treatment of relapse of depressionP N Dannon, S Schreiber, O T Dolberg, et al.Journal of Clinical Psychopharmacology|February 1, 1989
Panic attacks and agoraphobia: low dose clomipramine treatmentS Gloger, L Grunhaus, D Gladic, et al.Clinical Neuropharmacology|October 1, 1988
Major depressive disorder and panic disorder. Effects of comorbidity on treatment outcome with antidepressant medicationsL Grunhaus, Y Harel, T Krugler, et al.Biological Psychiatry|April 3, 1999
Chronic treatment with repetitive transcranial magnetic stimulation inhibits seizure induction by electroconvulsive shock in ratsA Fleischmann, S Hirschmann, O T Dolberg, et al.Acta Psychiatrica Scandinavica|April 1, 1990
Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factorsJ H Meador-Woodruff, J F Greden, L Grunhaus, et al.The American Journal of Psychiatry|August 1, 1982
The dexamethasone suppression test in panic disorder and agoraphobiaG C Curtis, O G Cameron, R M NessePsychiatry Research|July 1, 1985
Anxiety and caffeine consumption in people with anxiety disordersM A Lee, O G Cameron, J F GredenJournal of Psychiatric Research|March 1, 1996
Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisolJ L Abelson, G C Curtis, O G CameronPageof 12